Hudock, Inc. Viatris Inc Transaction History

Hudock, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$8.48 - $11.13 $25 - $33	3 Added 0.1%	3,089 $26,000
Q2 2022 Aug 02, 2022	SELL	$9.95 - $12.27 $7,661 - $9,447	-770 Reduced 19.97%	3,086 $32,000
Q1 2022 May 02, 2022	SELL	$9.81 - $15.4 $716 - $1,124	-73 Reduced 1.86%	3,856 $41,000
Q4 2021 Jan 19, 2022	SELL	$12.09 - $14.68 $411 - $499	-34 Reduced 0.86%	3,929 $53,000
Q3 2021 Nov 09, 2021	SELL	$13.25 - $15.13 $1,722 - $1,966	-130 Reduced 3.18%	3,963 $53,000
Q2 2021 Aug 09, 2021	SELL	$12.97 - $16.15 $25 - $32	-2 Reduced 0.05%	4,093 $58,000
Q1 2021 Apr 26, 2021	BUY	$13.59 - $18.54 $733 - $1,001	54 Added 1.34%	4,095 $57,000
Q4 2020 Feb 05, 2021	BUY	$14.3 - $18.74 $57,786 - $75,728	4,041 New	4,041 $75,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.